97 related articles for article (PubMed ID: 7636898)
1. Tumor necrosis factor-induced necrosis: a monocyte-mediated hypercoagulable effect.
Spillert CR; Sun S; Ponnudurai R; Miller MA; Lazaro EJ
J Natl Med Assoc; 1995 Jul; 87(7):508-9. PubMed ID: 7636898
[TBL] [Abstract][Full Text] [Related]
2. Effect of advanced glycation end product-modified albumin on tissue factor expression by monocytes. Role of oxidant stress and protein tyrosine kinase activation.
Khechai F; Ollivier V; Bridey F; Amar M; Hakim J; de Prost D
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2885-90. PubMed ID: 9409271
[TBL] [Abstract][Full Text] [Related]
3. Induction of tissue factor activity in endothelial cells and monocytes by a modified form of albumin present in normal human plasma.
Faucette KJ; Parker CJ; McCluskey T; Bernshaw NJ; Rodgers GM
Blood; 1992 Jun; 79(11):2888-95. PubMed ID: 1586736
[TBL] [Abstract][Full Text] [Related]
4. Contribution of the monocyte to thrombotic potential.
Spillert CR; Lazaro EJ
Agents Actions; 1991 Sep; 34(1-2):28-9. PubMed ID: 1793044
[TBL] [Abstract][Full Text] [Related]
5. The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. An assay for detection of endotoxin.
Osterud B; Bjørklid E
Scand J Haematol; 1982 Aug; 29(2):175-84. PubMed ID: 6813961
[TBL] [Abstract][Full Text] [Related]
6. Procoagulant activity of endotoxin or tumor necrosis factor activated monocytes is enhanced by IgG from patients with lupus anticoagulant.
Schved JF; Gris JC; Ollivier V; Wautier JL; Tobelem G; Caen J
Am J Hematol; 1992 Oct; 41(2):92-6. PubMed ID: 1415187
[TBL] [Abstract][Full Text] [Related]
7. Hypercoagulability in arterial disease.
Spillert CR; Milazzo VJ; Suval WD; Lazaro EJ
Angiology; 1989 Oct; 40(10):886-9. PubMed ID: 2802258
[TBL] [Abstract][Full Text] [Related]
8. [Inhibition by pentoxifylline of procoagulant activity produced by endotoxin-active monocytes].
de Prost D; Ollivier V; Hakim J
C R Seances Soc Biol Fil; 1992; 186(3):186-92. PubMed ID: 1283564
[TBL] [Abstract][Full Text] [Related]
9. Nicotinamide inhibits endotoxin-induced monocyte tissue factor expression.
Ungerstedt JS; Heimersson K; Söderström T; Hansson M
J Thromb Haemost; 2003 Dec; 1(12):2554-60. PubMed ID: 14675092
[TBL] [Abstract][Full Text] [Related]
10. Thrombin enhances monocyte secretion of tumor necrosis factor and interleukin-1 beta by two distinct mechanisms.
Hoffman M; Cooper ST
Blood Cells Mol Dis; 1995; 21(2):156-67. PubMed ID: 8846045
[TBL] [Abstract][Full Text] [Related]
11. Endotoxin-induced procoagulant activity in equine peripheral blood monocytes.
Henry MM; Moore JN
Circ Shock; 1988 Nov; 26(3):297-309. PubMed ID: 3208423
[TBL] [Abstract][Full Text] [Related]
12. The mandatory role of complement in the endotoxin-induced synthesis of tissue thromboplastin in blood monocytes.
Osterud B; Eskeland T
FEBS Lett; 1982 Nov; 149(1):75-9. PubMed ID: 7152036
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor measurement and use of different anticoagulants: possible interference in plasma samples and supernatants from endotoxin-stimulated monocytes.
Hoffmann JN; Hartl WH; Faist E; Jochum M; Inthorn D
Inflamm Res; 1997 Sep; 46(9):342-7. PubMed ID: 9339389
[TBL] [Abstract][Full Text] [Related]
14. TNF 41-62 and TNF 78-96 have distinct effects on LPS-induced tissue factor activity and the production of cytokines in human blood cells.
Eliassen LT; Rekdal O; Svendsen JS; Osterud B
Thromb Haemost; 2000 Apr; 83(4):598-604. PubMed ID: 10780324
[TBL] [Abstract][Full Text] [Related]
15. Assessment of monocyte function in breast disease.
Spillert CR; Curtis GT; Lazaro EJ
South Med J; 1988 Feb; 81(2):164-6. PubMed ID: 3277286
[TBL] [Abstract][Full Text] [Related]
16. The incubation of human blood monocytes with tumor necrosis factor-alpha leads to lysis of tumor necrosis factor-sensitive but not resistant tumor cells.
Nii A; Fidler IJ
Lymphokine Res; 1990; 9(2):113-24. PubMed ID: 2338840
[TBL] [Abstract][Full Text] [Related]
17. Pentoxifylline: a potential treatment for thrombosis associated with abnormal tissue factor expression by monocytes and endothelial cells.
de Prost D
J Cardiovasc Pharmacol; 1995; 25 Suppl 2():S114-8. PubMed ID: 8699848
[TBL] [Abstract][Full Text] [Related]
18. Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors.
Kirchhofer D; Tschopp TB; Hadváry P; Baumgartner HR
J Clin Invest; 1994 May; 93(5):2073-83. PubMed ID: 8182139
[TBL] [Abstract][Full Text] [Related]
19. Shortened endotoxin-activated clotting times in patients with carcinoma.
Spillert CR; Lazaro EJ
Am Surg; 1987 Mar; 53(3):164-6. PubMed ID: 3548512
[TBL] [Abstract][Full Text] [Related]
20. Neutrophils activated by granulocyte colony-stimulating factor suppress tumor necrosis factor-alpha release from monocytes stimulated by endotoxin.
Terashima T; Soejima K; Waki Y; Nakamura H; Fujishima S; Suzuki Y; Ishizaka A; Kanazawa M
Am J Respir Cell Mol Biol; 1995 Jul; 13(1):69-73. PubMed ID: 7541223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
